http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102850344-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_327804b51d47ff6afc403138b838f3f5
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2011-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_573ea036b173978863b710b798ee035e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2928f96f4f4497a744f013e89fc4fd6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4977d1ab411e34e54016503c2fc8767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03608502253980566fdc42abad263ed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6195112f9f8e5c3497a477b043e24c4d
publicationDate 2013-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102850344-A
titleOfInvention The medicinal use of penehyclidine optical isomer derivatives for anti-tumor
abstract The present invention provides penehyclidine optical isomer derivatives with anti-tumor effects and their non-toxic pharmaceutically available salts, pharmaceutical compositions containing these compounds as active ingredients, and their anti-tumor effects.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109851615-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109851615-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016528199-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104072345-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104072345-B
priorityDate 2011-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468015599

Total number of triples: 22.